A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

NCT01921712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: PUR0200
DRUG: PUR0200 Placebo
DRUG: Active comparator

Sponsor

Pulmatrix Inc.

Collaborators

[object Object]